SEP 9, 2026 · JOURNAL ARTICLE
DNV-TC: a developmental network vulnerability-based classification system for precision oncology
Frontiers in Cell and Developmental Biology
A retrospective, in silico classification framework proposal with no prospective validation, experimental confirmation, or clinical trial evidence; the authors explicitly acknowledge the need for external validation.
Reported
Therapy response rate in high net…87%
Median time to resistance in resp…6–8 months
Hazard ratio for network vulnerab…2.3